title: MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.
authors.forename: M M
authors.initials: MM
authors.lastname: Patnaik
authors.forename: T L
authors.initials: TL
authors.lastname: Lasho
authors.forename: C M
authors.initials: CM
authors.lastname: Finke
authors.forename: N
authors.initials: N
authors.lastname: Gangat
authors.forename: D
authors.initials: D
authors.lastname: Caramazza
authors.forename: S
authors.initials: S
authors.lastname: Siragusa
authors.forename: C A
authors.initials: CA
authors.lastname: Hanson
authors.forename: A
authors.initials: A
authors.lastname: Pardanani
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D005260:Female; D005838:Genotype; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D053628:Receptors, Thrombopoietin / Q000235:genetics*
chemical_list: D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2